Mortality, economic cost associated with pulmonary alveolar proteinosis highlighted for first time at conference
The overall annual cost burden of the United States for patients admitted with pulmonary alveolar proteinosis (PAP) was approximately $5 million, according to study results presented at CHEST Annual Meeting 2020.
The study, which sought to provide new information on epidemiological and resource utilization data on PAP is the first U.S. analysis of the incidence, mortality, and economic cost of this patient population.
Over the course of 3 years, 500 patients with a primary diagnosis of PAP were admitted to the hospital with a mean age of 41.45 years. Approximately 58% were Caucasian and 55% were men. Out of the 500 cases, 195 whole lung lavage procedures were performed. Hospital mortality rate was 5%, with mean length of stay was 6.2 days. The mean charges were $100,257 and mean actual costs per admission were $29,932.
The authors hope that this data will lead to a better understanding of PAP.
Tome RG, et al. Incidence, mortality and characteristics of patients admitted with pulmonary alveolar proteinosis in the United States. Presented at: CHEST Annual Meeting 2020.